Bluebird Bio Stock Options

BLUE Stock  USD 0.92  0.05  5.15%   
Bluebird Bio's option chain provides insight into all available option contracts written on Bluebird Bio's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Bluebird Bio's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Bluebird option contract.

In The Money vs. Out of Money Option Contracts on Bluebird Bio

Analyzing Bluebird Bio's in-the-money options over time can help investors to take a profitable long position in Bluebird Bio regardless of its overall volatility. This is especially true when Bluebird Bio's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Bluebird Bio's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Bluebird Bio's stock while costing only a fraction of its price.
Bluebird Bio's latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 175.85 with a put-to-call open interest ratio of 0.2 over 26 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 116, with calls trading at the volume of 60. This yields a 1.93 put-to-call volume ratio. The Bluebird Bio option chain provides detailed quote and price information for the current Bluebird bio option contracts. It shows all of Bluebird Bio's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2024-05-17 Option Contracts

Bluebird Bio option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Bluebird Bio's lending market. For example, when Bluebird Bio's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Bluebird Bio, he or she must hedge the risk by shorting Bluebird Bio stock over its option's life.
The chart above shows Bluebird Bio's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Bluebird Bio's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Bluebird Bio's option, there is no secondary market available for investors to trade.
Bluebird Bio's stock options are financial instruments that give investors the right to buy or sell shares of Bluebird bio common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Bluebird stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Bluebird Bio's stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.
Please note that buying 'in-the-money' options on Bluebird Bio lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Bluebird Bio's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Bluebird Bio contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Bluebird Stock moves the wrong way.
At present, Bluebird Bio's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 1 M, whereas Common Stock Total Equity is forecasted to decline to about 431.4 K.

Bluebird bio In The Money Call Balance

When Bluebird Bio's strike price is surpassing the current stock price, the option contract against Bluebird bio stock is said to be in the money. When it comes to buying Bluebird Bio's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Bluebird bio are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Bluebird Current Options Market Mood

Bluebird Bio's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Bluebird Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Bluebird Bio's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Bluebird Bio's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Bluebird Bio's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Bluebird contract

Base on the Rule 16, the options market is currently suggesting that Bluebird bio will have an average daily up or down price movement of about 10.99% per day over the life of the 2024-05-17 option contract. With Bluebird Bio trading at USD 0.92, that is roughly USD 0.1. If you think that the market is fully incorporating Bluebird Bio's daily price movement you should consider buying Bluebird bio options at the current volatility level of 175.85%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Bluebird Bio options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Bluebird calls. Remember, the seller must deliver Bluebird bio stock to the call owner when a call is exercised.

Bluebird Bio Option Chain

When Bluebird Bio's strike price is surpassing the current stock price, the option contract against Bluebird bio stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Bluebird Bio's option chain is a display of a range of information that helps investors for ways to trade options on Bluebird. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Bluebird. It also shows strike prices and maturity days for a Bluebird Bio against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2024-05-17 CALL at $0.50.88350.22562382024-05-170.25 - 0.551.2In
Call
2024-05-17 CALL at $1.00.52071.426422432024-05-170.1 - 0.150.1Out
Call
2024-05-17 CALL at $3.00.1650.313921522024-05-170.0 - 0.050.05Out
 Put
2024-05-17 PUT at $10.0-0.91510.136102024-05-178.7 - 9.40.0In
 Put
2024-05-17 PUT at $7.5-0.66120.2302024-05-176.5 - 6.94.6In
 Put
2024-05-17 PUT at $5.5-0.80380.240802024-05-174.2 - 5.02.7In
 Put
2024-05-17 PUT at $5.0-0.80120.25141642024-05-173.9 - 4.33.9In
 Put
2024-05-17 PUT at $4.5-0.79830.264242024-05-173.2 - 4.01.75In
 Put
2024-05-17 PUT at $4.0-0.5790.2705142024-05-172.8 - 3.72.65In
 Put
2024-05-17 PUT at $3.5-0.70450.3103742024-05-172.5 - 2.82.5In
 Put
2024-05-17 PUT at $3.0-0.62530.3223802024-05-172.0 - 2.41.73In
 Put
2024-05-17 PUT at $2.5-0.89270.31339042024-05-171.5 - 1.61.55In
 Put
2024-05-17 PUT at $2.0-0.38980.26169252024-05-170.85 - 1.41.02In
 Put
2024-05-17 PUT at $1.5-0.84930.677732292024-05-170.5 - 0.550.5In
 Put
2024-05-17 PUT at $1.0-0.46941.271115112024-05-170.1 - 0.150.14In

Bluebird Bio Total Stockholder Equity Over Time

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
   Total Stockholder Equity   
       Timeline  

Bluebird Bio Common Stock Total Equity Over Time

The total value of common stock equity held by shareholders, representing their ownership interest in the company.
   Common Stock Total Equity   
       Timeline  

Bluebird Total Stockholder Equity

Total Stockholder Equity

214.5 Million

At present, Bluebird Bio's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bluebird Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Commodity Channel Now

   

Commodity Channel

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Bluebird Bio Corporate Directors

Bluebird Bio corporate directors refer to members of a Bluebird Bio board of directors. The board of directors generally takes responsibility for the Bluebird Bio's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bluebird Bio's board members must vote for the resolution. The Bluebird Bio board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Elizabeth PingpankDirector CommunicationsProfile
James MandellDirectorProfile
John MaraganoreIndependent DirectorProfile
Manisha PaiSr. Director, Investor RelationsProfile

Already Invested in Bluebird bio?

The danger of trading Bluebird bio is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bluebird Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bluebird Bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bluebird bio is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Bluebird bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Bluebird Stock analysis

When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Is Bluebird Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.63)
Revenue Per Share
0.214
Quarterly Revenue Growth
173.535
Return On Assets
(0.15)
Return On Equity
(0.48)
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.